NOV 14, 2017 12:00 PM PST

WEBINAR: Exosome miRNA sequencing for biomarker profiling using the Ion S5 System and Ion Total RNA-seq kit

Speaker

Abstract

DATE: November 14, 2017
TIME: 12:00pm PST, 03:00pm EST

Learning Objectives:

  • How to maximise RNA yield and extraction from exosomes and biological fluids
  • How to construct small RNA libraries from low RNA yields
  • How to analyze your small RNA reads to select a list of biomarker candidates for validation

Alzheimer’s disease (AD) affects more than 55 million people worldwide and is expected to double every 20 years in the absence of disease-modifying drugs. Future therapeutic strategies aimed at limiting neurodegeneration require methods to diagnose the disease in preclinical patients. Several blood-based tests have been explored to detect AD however, evidence is required to determine whether blood sampling is an appropriate specimen to diagnose brain diseases. Previously we isolated serum exosomes from AD patients which displayed an abnormal composition of 16 specific microRNA (miRNA) biomarkers compared to controls. To provide evidence that our serum exosomal miRNA biomarkers are suitable for the detection of a brain condition, we also profiled exosomes isolated from post-mortem human AD and control brain tissues. Exosomes were extensively characterised to meet the minimal experiments requirements set out by The International Society for Extracellular Vesicles to be defined as exosomes and small RNA profiling was performed by next-generation sequencing.

The Ion Torrent Ion S5 and Ion Chef system was used to perform small RNA deep sequencing of the brain and serum exosome samples. Brain derived exosomes (BDEs) were found to contain a unique profile of small RNA, including miRNA, compared to whole tissue samples. Furthermore, all 16 serum biomarkers, identified in our previous study, were detected in BDEs including a panel of BDE specific miRNA that target genes involved in AD pathology. This work has identified a highly specific panel of miRNA that is both present in the brain and blood of AD patient samples. In the future, the miRNA candidates could be used to develop a blood-based diagnostic test highly relevant to a brain disease, equivalent to non-invasive brain biopsy. Furthermore, this biomarker discovery pipeline could be used to identify exosomal miRNA biomarkers for other diseases and conditions.

For Research Only. Not for use in diagnostic procedures


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
DEC 16, 2020 8:00 AM PST
C.E. CREDITS
DEC 16, 2020 8:00 AM PST
Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
NOV 14, 2017 12:00 PM PST

WEBINAR: Exosome miRNA sequencing for biomarker profiling using the Ion S5 System and Ion Total RNA-seq kit


Specialty

Cancer Research

Molecular Biology

Cell Biology

Biotechnology

Molecular Diagnostics

Biomarkers

Cancer Diagnostics

Genetics

Dna

Clinical Diagnostics

Immunology

Cell Culture

Genomics

Gene Expression

Dna Sequencing

Geography

North America57%

Europe18%

Asia10%

South America4%

Africa4%

Oceania3%

Registration Source

Website Visitors100%

Job Title

Research Scientist18%

Student17%

Scientist13%

Educator/Faculty9%

Executive8%

Post Doc7%

Medical Laboratory Technician7%

Medical Doctor/Specialist5%

Lab Management4%

Clinical Laboratory Scientist4%

Biologist3%

Marketing/Sales3%

Facility/Department Manager3%

Organization

Academic Institution13%

Research Institute7%

Biotech Company6%

Hospital5%

Clinical Laboratory5%

Medical School3%

Ambulatory Care2%

Life Science Company2%

Government2%

Pharmaceutical Company2%

Medical Center1%

Non-Profit Organization1%

Medical Device Company1%

Consultant1%

Other3%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more